References
- Sen CK Gordillo GM Roy S Human skin wounds: a major and snowballing threat to public health and the economy Wound Repair Regen 2009 17 6 763 771 19903300
- Guo S Dipietro LA Factors affecting wound healing J Dent Res 2010 89 3 219 229 20139336
- Dobie D Gray J Fusidic acid resistance in Staphylococcus aureus Arch Dis Child 2004 89 1 74 77 14709515
- Kresken M Hafner D Schmitz FJ Wichelhaus TA Prevalence of mupirocin resistance in clinical isolates of Staphylococcus aureus and Staphylococcus epidermidis: results of the Antimicrobial Resistance Surveillance Study of the Paul-Ehrlich-Society for Chemotherapy, 2001 Int J Antimicrob Agents 2004 23 6 577 581 15194128
- Chambers HF Deleo FR Waves of resistance: Staphylococcus aureus in the antibiotic era Nat Rev Microbiol 2009 7 9 629 641 19680247
- Mohamed MF Hamed MI Panitch A Seleem MN Targeting methicillin-resistant Staphylococcus aureus with short salt-resistant synthetic peptides Antimicrob Agents Chemother 2014 58 7 4113 4122 24798285
- Hancock RE Sahl HG Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies Nat Biotechnol 2006 24 12 1551 1557 17160061
- Montgomery CP Daniels MD Zhao F Spellberg B Chong AS Daum RS Local inflammation exacerbates the severity of Staphylococcus aureus skin infection PloS One 2013 8 7 e69508 23861974
- King MD Humphrey BJ Wang YF Kourbatova EV Ray SM Blumberg HM Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections Ann Intern Med 2006 144 5 309 317 16520471
- Kumar JK Lysostaphin: an antistaphylococcal agent Appl Microbiol Biotechnol 2008 80 4 555 561 18607587
- Desbois AP Gemmell CG Coote PJ In vivo efficacy of the antimicrobial peptide ranalexin in combination with the endopeptidase lysostaphin against wound and systemic meticillin-resistant Staphylococcus aureus (MRSA) infections Int J Antimicrob Agents 2010 35 6 559 565 20206480
- Kokai-Kun JF Walsh SM Chanturiya T Mond JJ Lysostaphin cream eradicates Staphylococcus aureus nasal colonization in a cotton rat model Antimicrob Agents Chemother 2003 47 5 1589 1597 12709327
- Kusuma C Jadanova A Chanturiya T Kokai-Kun JF Lysostaphin-resistant variants of Staphylococcus aureus demonstrate reduced fitness in vitro and in vivo Antimicrob Agents Chemother 2007 51 2 475 482 17101683
- Cho JS Zussman J Donegan NP Noninvasive in vivo imaging to evaluate immune responses and antimicrobial therapy against Staphylococcus aureus and USA300 MRSA skin infections J Invest Dermatol 2011 131 4 907 915 21191403
- Cho JS Pietras EM Garcia NC IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice J Clin Invest 2010 120 5 1762 1773 20364087
- De Vry CG Valdez M Lazarov M Topical application of a novel immunomodulatory peptide, RDP58, reduces skin inflammation in the phorbol ester-induced dermatitis model J Invest Dermatol 2005 125 3 473 481 16117788
- Ward B Seal BL Brophy CM Panitch A Design of a bioactive cell-penetrating peptide: when a transduction domain does more than transduce J Pept Sci 2009 15 10 668 674 19691016
- Lopes LB Brophy CM Flynn CR A novel cell permeant peptide inhibitor of MAPKAP kinase II inhibits intimal hyperplasia in a human saphenous vein organ culture model J Vasc Surg 2010 52 6 1596 1607 20864298
- Schmelcher M Powell AM Becker SC Camp MJ Donovan DM Chimeric phage lysins act synergistically with lysostaphin to kill mastitis-causing Staphylococcus aureus in murine mammary glands Appl Environ Microbiol 2012 78 7 2297 2305 22286996
- Rubin BK Tamaoki J Antibiotics as Anti-inflammatory and Immunomodulatory Agents Basel Birkhaäuser 2005
- Miller LS Cho JS Immunity against Staphylococcus aureus cutaneous infections Nat Rev Immunol 2011 11 8 505 518 21720387
- Cho JS Guo Y Ramos RI Neutrophil-derived IL-1β is sufficient for abscess formation in immunity against Staphylococcus aureus in mice PloS Pathog 2012 8 11 e1003047 23209417
- Jialal I Miguelino E Griffen SC Devaraj S Concomitant reduction of low-density lipoprotein-cholesterol and biomarkers of inflammation with low-dose simvastatin therapy in patients with type 1 diabetes J Clin Endocrinol Metab 2007 92 8 3136 3140 17519305
- Wallace HJ Stacey MC Levels of tumor necrosis factor-alpha (TNF-alpha) and soluble TNF receptors in chronic venous leg ulcers – correlations to healing status J Invest Dermatol 1998 110 3 292 296 9506452
- Cowin AJ Hatzirodos N Rigden J Fitridge R Belford DA Etanercept decreases tumor necrosis factor-alpha activity in chronic wound fluid Wound Repair Regen 2006 14 4 421 426 16939569
- Donath MY Targeting inflammation in the treatment of type 2 diabetes: time to start Nat Rev Drug Discov 2014 13 6 465 476 24854413
- Khanna S Biswas S Shang Y Macrophage dysfunction impairs resolution of inflammation in the wounds of diabetic mice PloS One 2010 5 3 e9539 20209061